What Elysia Raytest does

Elysia-Raytest is a privately held manufacturer and solutions provider of radioactivity measurement, radiopharmaceutical quality-control (QC), and laboratory information management systems (LIMS), serving the global nuclear medicine and positron emission tomography (PET) ecosystem. The company is structured as Elysia s.a. (Belgium, primary corporate entity, headquartered in Angleur/Liège) and Elysia-raytest GmbH (Germany, manufacturing and logistics in Straubenhardt), with a direct US sales office in Miami; it originates from the 2015 acquisition of Raytest Isotopenmessgeräte GmbH (founded 1980) by Elysia S.A. Its product portfolio spans three layers: (1) core instruments — radio-HPLC flow monitors (RAMONA Star/Quattro, GABI Nova, MIRA Star, POMO Nova), gamma multi-channel analysers (MUCHA Nova series, HPGe detectors), dose calibrators, synthesis modules (GAIA, LUNA), osmometers and radio-TLC systems; (2) turn-key solutions such as QC-Cubicle packages for FDG and 68Ga radiopharmaceuticals and the AURAS automated radioactive sample-handling system; and (3) software including GINA X (centralised SQL-based chromatography/spectroscopy data acquisition), SARA (batch reporting), BIOTRAX QMS (paperless LIMS for radio pharmacies), AIDA (image analysis), and integrations with third-party platforms (Clarity, Genie 2000, Endosafe NexGen, Shimadzu/Agilent HPLC).

Name

Elysia Raytest

Legal name

Elysia-raytest GmbH / Elysia s.a.

Website

https://elysia-raytest.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

1–10 employees

Short description

Elysia-Raytest designs, manufactures, and services radioactivity measurement instruments, chromatography/QC systems, and radio-pharmacy LIMS software for hospitals, PET facilities, and radiopharmaceutical producers across global nuclear medicine markets.

Ownership category

akta.pro rank

Product category

Nuclear Medicine Equipment and Radiopharmaceutical Quality Control

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Testing Laboratories and Services (54138)

SIC

Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841), Industrial Instruments For Measurement, Display, And Control (3823), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Radiopharmacy Compounding & Dispensing (Hospital/Commercial) (HLAIAGAE)

akta.pro secondary industries

Analytical Instruments & Chromatography Systems (HLAGAIAA), Nuclear Medicine & Molecular Imaging (SPECT/PET) (HLAHABAE), Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine) (HLAIAGAJ), Radiation Detection Instruments & Systems (Portal monitors, spectrometers, contamination monitors) (EUAKAIAK)

Keywords

• Radiopharmaceutical quality control
• Radioactivity measurement instruments
• Nuclear medicine equipment
• Chromatography data systems
• Laboratory information management

Headquarters

HQ city

Urdorf

HQ country

Switzerland

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Instruments and Hardware Sales: Sale of radioactivity measurement instruments including radio-detectors, dose calibrators, multi-channel analysers, HPLC systems, and synthesis modules. Products are manufactured in Germany and Belgium with ISO 9001 quality certification.
2. Software Licenses and Subscriptions: Sale and licensing of software solutions including GINA X chromatography software, SARA reporting system, BIOTRAX LIMS, and AIDA image analysis software. Software designed for GMP environments with 21 CFR Part 11 compliance.
3. Service and Support: Comprehensive service offerings including system training, validation services, instrument servicing, method development, and method training. Remote support via TeamViewer and on-site service worldwide.
4. Turn-Key Solutions: Complete integrated solutions including QC-Cubicle turn-key labs, AURAS automated QC systems, and synthesis modules for radiopharmaceutical production.

Go-to-market motion1 record

Distribution channels15 records

Marketing channels4 records

Core offering

Elysia-Raytest designs, manufactures, sells and services instruments and software used in radioactivity measurement and quality control for the nuclear medicine, PET, pharmaceutical and agrochemical industries. Its portfolio spans radio-detectors (RAMONA, GABI Nova, MIRA Star, POMO Nova), multi-channel analyzers (MUCHA Nova, HPGe), dose calibrators, radio-HPLC systems (HIPER FDG), synthesis modules (GAIA, LUNA), turn-key QC laboratories (QC-Cubicle), automated sample handling (AURAS), and proprietary software platforms (GINA X, SARA, BIOTRAX LIMS, AIDA, Clarity) for chromatography, spectroscopy, reporting, and inventory management in cGMP-compliant radiopharmacy environments.

Product overview

Elysia-Raytest is a provider of LIMS, chromatography, quality control systems, and instruments for the pharmaceutical, agrochemical, nuclear medicine, and PET industries. The company designs, manufactures, sells, and services instruments used in radioactivity measurement and quality control. The product portfolio consists of three integrated layers: (1) Core instruments including radioactivity detectors (RAMONA, GABI Nova, MIRA Star, POMO Nova), multi-channel analyzers (MUCHA Nova, HPGe), dose calibrators, and radio-HPLC systems; (2) Turn-key solutions including the QC-Cubicle line for radiopharmaceutical production QC and AURAS for automated sample handling, all integrated with the GINA X software platform for data acquisition and the SARA software for batch reporting and LIMS connectivity; (3) Software products including GINA X (chromatography/spectroscopy data acquisition), Clarity (DataApex chromatography), SARA (smart report analysis), BioTrax QMS (paperless LIMS for radio pharmacies), and AIDA (image analysis). The company also offers comprehensive services including system training, validation, instrument servicing, and method development/training, all manufactured in Germany and Belgium with ISO 9001 certification.

Differentiator

Problem solved

Functional benefit

Brands

• AURAS: Automated Radioactive Sample-handling module for automated quality control of radiopharmaceuticals
• GINA X
• AURAS Prep Module
• QC-Cubicle
• BIOTRAX
• SARA
• AIDA
• MUCHA Nova
• GAIA
• ELYSHIELD
• SYSHIELD
• EISHE

Products and services

• GINA X
• AURAS
• AURAS Prep Module
• QC-Cubicle
• FDG QC-Cubicle
• 68Ga QC-Cubicle
• RAMONA Star
• RAMONA Quattro
• GABI Nova
• MIRA Star
• POMO Nova
• MUCHA Nova
• MUCHA Nova HR
• HPGe Detector
• Touch Screen Dose Calibrator
• HIPER FDG
• GAIA
• LUNA
• Clarity
• SARA
• BioTrax QMS
• AIDA
• SYSHIELD Syringe Shields
• EISHE Injection Screens
• Class A Isolators - Hot Cells
• Shielded Laminar Air Flow
• Shielded Cabinets
• System Training
• Elysia System Validation
• Instrument Servicing
• Method Development
• Method Training

Quantifiable outcome

• QC can be performed in less than 2m² of laboratory space
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration12 records

AI capability2 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• GammadatacoreChannel Partner/ Reseller/ Distributor · 1 January 2025Uppsala, Sweden-based company appointed as exclusive distributor for Scandinavia (Denmark, Norway, Sweden, and Finland) since 1 January 2025.
• Raytest Isotopenmessgeräte GmbHcoreStrategic or Co-development Partner · 1 October 2015Elysia S.A. acquired Raytest Isotopenmessgeräte GmbH in October 2015, combining Raytest's long development and production experience with Elysia's capabilities. The merged entity operates as Elysia-raytest.
• IBAcoreTechnology or IntegrationCyclotron manufacturer whose equipment is compatible with Elysia-raytest quality control and synthesis systems. Listed as a cyclotron producer partner on the company's support pages.
• GE HealthcarecoreTechnology or IntegrationCyclotron and PET equipment manufacturer whose systems are compatible with Elysia-raytest QC solutions. Listed as cyclotron producer partner.
• Best Cyclotron SystemscoreTechnology or IntegrationCyclotron manufacturer partner whose equipment is compatible with Elysia-raytest quality control systems.
• RadioprotechcoreChannel Partner/ Reseller/ DistributorProvider of lead protection products including hot cells and syringe protectors. Partnership announced to complement Elysia-Raytest portfolio in nuclear medicine and radiotherapy. Provides Class A isolators, shielded laminar air flow, and small protection equipment.
• Rad4MedminorStrategic or Co-development PartnerBelgian Network for Radiation Applications in Healthcare. Elysia joined as member to connect with the Belgian healthcare radiation applications community.
• Cyclotron Research Center (CRC), University of LiègecoreStrategic or Co-development PartnerClose collaboration with CRC provides Elysia with own laboratories including Hot Cells and cyclotron access, enabling development and validation of new technologies and QC methods using various radiotracers.
• Charles River LaboratoriesminorChannel Partner/ Reseller/ DistributorProvider of Endosafe NexGen system for endotoxin detection, integrated into Elysia's turn-key solutions for microbiological quality control testing.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• GE Healthcare: GE Healthcare is a broad incumbent in nuclear medicine and PET imaging, with cyclotron/PET-tracer production systems (named as a partner by Elysia-Raytest); its scale and vertically integrated QC offerings create indirect competitive pressure even where not directly head-to-head.
• Siemens Healthineers: Siemens is a broad incumbent in molecular imaging, SPECT/PET, and nuclear medicine workflows; its PETNET radiopharmacy network represents both an indirect competitor to Elysia-Raytest's QC solutions and a prospective customer base.
• Mirion Technologies: Mirion is a broad incumbent in radiation detection, dosimetry, and nuclear measurement — overlapping with Elysia-Raytest's multi-channel analyzers and radiation detection portfolio at a portfolio rather than specialty level.

Direct peers

• Trasis: Belgian Trasis competes directly with Elysia-Raytest's GAIA and LUNA modules in radiopharmaceutical synthesis modules for PET tracers and theranostics, with overlapping FDG/68Ga/Lu-177 synthesis capabilities.
• Comecer: Italian Comecer (ATS group) is a direct peer in shielded hot cells, laminar flow cabinets, and radiopharmacy equipment, complementing Elysia-Raytest's ELYSHIELD line; both companies provide infrastructure around radiopharmaceutical production and compounding.
• LabLogic Systems: UK-based LabLogic directly competes with Elysia-Raytest in radiochromatography, radiopharmacy QC, and LIMS software for PET/nuclear medicine departments — overlapping products include radio-HPLC detectors, dose calibrators, and Laura radiochromatography software.
• Tema Sinergie: Italian Tema Sinergie directly competes in PET and radiopharmacy equipment — including automated dispensing systems, QC workstations, and shielding — closely matching Elysia-Raytest's QC-Cubicle and AURAS offerings.
• Berthold Technologies: German Berthold competes in radioactivity measurement and radiation detection instruments for life sciences and nuclear medicine, overlapping with Elysia-Raytest's RAMONA, GABI Nova, and radio-detector families.

Others

• LabLogic Group / Laura software competitors (e.g., Agilent): Agilent is an adjacent HPLC platform provider whose instruments integrate into Elysia-Raytest's QC workflows; it is an enabling peer in laboratory chromatography rather than a direct competitor but shapes the integration requirements for radio-HPLC solutions.

Emerging players

• PETsys Electronics: Portuguese PETsys is an emerging player in PET detectors and readout electronics; partial overlap with Elysia-Raytest's radioactivity detection ecosystem for pre-clinical and clinical PET instrumentation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elysia Raytest